The dark cloud of recreational drugs and vaping
Individual Clinical
Pharmacokinetics
& Abuse Liability
Misuse Postential
Blundell (2018)
Dependence on Tobacco and Nicotine Products: A Case for Product-Specific Assessment
Individual Clinical
Pharmacokinetics
& Abuse Liability
Abuse Liability
Fagerstrom and Eissenberg (2012)
E-cigarette Nicotine Delivery: Data and Learnings from Pharmacokinetic Studies
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Fearon (2017)
Urinary cotinine levels of electronic cigarette (e-cigarette) users
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Goney (2016)
Computational analysis of deposition and translocation of inhaled nicotine and acrolein in the human body with e-cigarette puffing topographies
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Haghnegahdar (2018)
Nicotine Delivery Kinetics and Abuse Liability
Individual Clinical
Pharmacokinetics
& Abuse Liability
Abuse Liability
Henningfield and Keenan (1993)
Combined analysis of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Kotandeniya (2015)
Abuse liability assessment of an electronic cigarette in combustible cigarette smokers.
Individual Clinical
Pharmacokinetics
& Abuse Liability
Abuse Liability
Maloney (2019)
Nicotine Blood Levels and Short-term Smoking Reduction with an Electronic Nicotine Delivery System
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Nides (2014)
Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Papaseit (2017)